• Home
  • Medical Policy Update

Medical Policy Update

Blue Cross and Blue Shield of Kansas (BCBSKS) has published the following updated medical policies on the BCBSKS Website. Click on a link to view the details of each policy.

Published 08/23/22:

  • Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or Bone
  • Genotype-Guided Tamoxifen Treatment
  • Miscellaneous Genetic and Molecular Diagnostic Tests
  • Radiofrequency Ablation of Primary or Metastatic Liver Tumors
  • Risk-Reducing Mastectomy
  • Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Metastatic Colorectal Cancer (KRAS, NRAF, BRAF, MMR/MSI, HER2, and TMB)
  • Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
  • Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies
  • Tumor Treating Fields Therapy
  • Hyperbaric Oxygen Therapy (HBOT) - Archived

If you have questions regarding this publication, please contact your BCBSKS provider consultant/representative.

Institutional Providers
Professional Providers